Skip to main content
Published locations for FDA advises against azithromycin use in allo-HSCT recipients
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA advises against azithromycin use in allo-HSCT recipients
User login
Username
Password
Reset your password
/content/fda-advises-against-azithromycin-use-allo-hsct-recipients
/hematology-oncology/article/184797/transplantation/fda-advises-against-azithromycin-use-allo-hsct-recipients
/hematologytimes/article/184797/transplantation/fda-advises-against-azithromycin-use-allo-hsct